Лиза Хендриксон-Джек - Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма

49. Foroozanfard, F., M. Jamilian, Z. Jafari, A. Khassaf, A. Hosseini, H. Khorammian, and Z. Asemi. “Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.” Experimental and Clinical Endocrinology and Diabetes 123, no. 04 (2015): 215–220; Ostadrahimi, Alireza. “Effect of zinc supplementation on cardiometabolic risk factors in women with polycystic ovary syndrome.” Journal of Cardiovascular and Thoracic Research 2, no. 2 (2010): 11–20.

50. Jamilian, Mehri, Fatemeh Foroozanfard, Fereshteh Bahmani, Rezvan Talaee, Mahshid Monavari, and Zatollah Asemi. “Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.” Biological Trace Element Research 170, no. 2 (2016): 271–278.

51. Wall, Rebecca, R. Paul Ross, Gerald F. Fitzgerald, and Catherine Stanton. “Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids.” Nutrition Reviews 68, no. 5 (2010): 280–289.

52. McEwen, Bradley J. “Can omega-3 polyunsaturated fatty acids improve metabolic profile in polycystic ovary syndrome (PCOS)?” Advances in Integrative Medicine 4, no. 2 (2017): 82–83; Khani, Behnaz, Farahnaz Mardanian, and Sajadeh Jafari Fesharaki. “Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome.” Journal of Research in Medical Sciences 22 (2017); Forouhi, Neda, Sakineh Shab-Bidar, and Kurosh Djafarian. “Effect of omega-3 fatty acids supplementation on testosterone levels in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.” Journal of Nutritional Sciences and Dietetics 1, no. 3 (2015): 165–170.

53. Ghent, W.R., B.A. Eskin, D.A. Low, and L.P. Hill. Iodine replacement in fibrocystic disease of the breast. Canadian Journal of Surgery 36, no. 5 (1993): 453–460; Naehrlich, Lutz, Helmuth-Günther Dörr, Azadeh Bagheri-Behrouzi, and Manfred Rauh. “Iodine deficiency and subclinical hypothyroidism are common in cystic fibrosis patients.” Journal of Trace Elements in Medicine and Biology 27, no. 2 (2013): 122–125.

54. Gerli, S., M. Mignosa, and G.C. Di Renzo. “Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.” European Review for Medical and Pharmacological Sciences 7 (2003): 151–160; Iuorno, MD, Maria J., Daniela J. Jakubowicz, MD, Jean-Patrice Baillargeon, MD, Pamela Dillon, BS, Ronald D. Gunn, MS, Geoffrey Allan, PhD, and John E. Nestler, MD. “Effects of D-chiro-inositol in lean women with the polycystic ovary syndrome.” Endocrine Practice 8, no. 6 (2002): 417–423.

55. Raffone, Emanuela, Pietro Rizzo, and Vincenzo Benedetto. “Insulin sensitiser agents alone and in co-treatment with r– FSH for ovulation induction in PCOS women.” Gynecological Endocrinology 26, no. 4 (2010): 275–280.

56. Dinicola, Simona, Tony T.Y. Chiu, Vittorio Unfer, Gianfranco Carlomagno, and Mariano Bizzarri. “The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.” The Journal of Clinical Pharmacology 54, no. 10 (2014): 1079–1092; Unfer, Vittorio, and Giuseppina Porcaro. “Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.” Expert Review of Clinical Pharmacology 7, no. 5 (2014): 623–631; Monastra, Giovanni, Vittorio Unfer, Abdel Halim Harrath, and Mariano Bizzarri. “Combining treatment with myo-inositol and D-chiro-inositol (40: 1) is effective in restoring ovary function and metabolic balance in PCOS patients.” Gynecological Endocrinology 33, no. 1 (2017): 1–9.

57. Millea, Paul J. “N-acetylcysteine: multiple clinical applications.” American Family Physician 80, no. 3 (2009): 265–269.

58. Salehpour, Saghar, Azadeh Akbari Sene, Nasrin Saharkhiz, Mohammad Reza Sohrabi, and Fatemeh Moghimian. “N– acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome.” Journal of Obstetrics and Gynaecology Research 38, no. 9 (2012): 1182–1186.

59. Javanmanesh, Forough, Maryam Kashanian, Maryam Rahimi, and Narges Sheikhansari. “A comparison between the effects of metformin and N-acetylcysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome.” Gynecological Endocrinology 32, no. 4 (2016): 285–289; Dasgupta, M., T.K. Roy, P.S. Mitra, S. Adhikari, and T. Bag. “Is N-acetylcysteine a better insulin sensitizer than metformin in polycystic ovarian syndrome?” Andrology & Gynecology: Current Research 3, no. 3. (2015): 1–5; Ali, Hina, Gita Radhakrishnan, and Alpana Singh. “Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, no. 7 (2017): 3076–3084; Cheraghi, Ebrahim, Malek Soleimani Mehranjani, Mohammad Ali Shariatzadeh, Mohammad Hossein Nasr Esfahani, and Zahra Ebrahimi. “N-acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin.” Reproduction, Fertility and Development 28, no. 6 (2016): 723–731.

60. Wei, Wei, Hongmin Zhao, Aili Wang, Ming Sui, Kun Liang, Haiyun Deng, Yukun Ma, Yajuan Zhang, Hongxiu Zhang, and Yuanyuan Guan. “A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.” European Journal of Endocrinology 166, no. 1 (2012): 99–105.

61. Li, Lin, Chengyan Li, Ping Pan, Xiaoli Chen, Xiaoke Wu, Ernest Hung Yu Ng, and Dongzi Yang. “A single arm pilot study of effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome.” PLOS One 10, no. 12 (2015): e0144072; Orio, Francesco, Giovanna Muscogiuri, Stefano Palomba, Silvia Savastano, Alessio Volpe, Marcello Orio, Giorgio Colarieti et al. “Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity.” e-SPEN Journal 8, no. 5 (2013): e200–e204.

62. Hajimonfarednejad, Mahdie, Majid Nimrouzi, Mojtaba Heydari, Mohammad Mehdi Zarshenas, Mohammad Javad Raee, and Bahia Namavar Jahromi. “Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: a randomized double-blind placebo controlled clinical trial.” Phytotherapy Research 32, no. 2 (2018): 276–283; Wang, Jeff G., Richard A. Anderson, George M. Graham, Micheline C. Chu, Mark V. Sauer, Michael M. Guarnaccia, and Rogerio A. Lobo. “The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study.” Fertility and Sterility 88, no. 1 (2007): 240–243.

63. Kort, Daniel H., and Roger A. Lobo. “Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial.” American Journal of Obstetrics and Gynecology 211, no. 5 (2014): 1–21.

64. Cialdella-Kam, Lynn, Charlotte P. Guebels, Gianni F. Maddalozzo, and Melinda M. Manore. “Dietary intervention restored menses in female athletes with exercise-associated menstrual dysfunction with limited impact on bone and muscle health.” Nutrients 6, no. 8 (2014): 3018–3039.

65. Reichman, Marsha E., Joseph T. Judd, Philip R. Taylor, Paomanabhan P. Nair, D.Y. Jones, and William S. Campbell. “Effect of dietary fat on length of the follicular phase of the menstrual cycle in a controlled diet setting.” The Journal of Clinical Endocrinology & Metabolism 74, no. 5 (1992): 1171–1175.